Biocytogen Boston Corp

This article introduces Biocytogen Boston Corp, a biotechnology company headquartered in Beijing, China.

To expand its efforts in antibody drug development, the company has established two divisions. One is BioMice, a contract research division that provides non-clinical study support to pharmaceutical companies, biotech firms, and academic institutions. The other focuses on the discovery and development of new antibody drugs for licensing and partnership opportunities.

Features of Biocytogen Boston Corp’s Contract Non-Clinical Research Services

Comprehensive support from early-stage drug discovery to IND submission

Before a drug can enter the market, it must undergo thorough evaluation of its efficacy, safety, and mechanism of action. Biocytogen Boston Corp provides custom gene editing services, animal and cell models, and comprehensive in vivo, ex vivo, and in vitro pharmacological testing to support efficient drug discovery from the earliest stages through IND submission.

In addition, the company offers a wide selection of established animal and cell models to accelerate research timelines.

Focus on a wide range of therapeutic areas

Biocytogen Boston Corp provides solutions with diverse disease models and integrated services to advance drug development across multiple therapeutic areas. This includes immuno-oncology, oncology, autoimmune diseases, inflammatory diseases, and neurological disorders.

Operation of large-scale animal facilities

In addition to its 55,000-square-meter SPF facility in Haimen, Jiangsu Province inChina, Biocytogen Boston Corp also operates smaller facilities in Daxing, Beijing in China, and Boston, USA. The Haimen Animal Center has been AAALAC-accredited since 2016, and the Beijing Animal Center has been certified since 2021. The company’s satellite facility in Boston also complies with the same international standards.

Example of Biocytogen Boston Corp’s Disease Models

Biocytogen provides a variety of disease models across different therapeutic areas. In oncology and immuno-oncology, one of the company's proprietary models include cell line-derived xenograft (CDX) models, in which human tumor cell lines are transplanted into immunodeficient mice, as well as humanized immune checkpoint mouse models.

Many other Models are also available for respiratory diseases such as asthma and pulmonary fibrosis, and for dermatological conditions such as psoriasis and atopic dermatitis.

Biocytogen Boston Corp Non-Clinical Case Studies

No specific case studies were available on the official website.

Company Information

In addition to its headquarters in Beijing, Biocytogen Boston Corp has offices in Nantong, Jiangsu Province, and in Boston, USA.